Clinical trial register · India

Clinical Trials in Hyderabad, 2026

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1120 matching records held by the registry are in this view. Synced 07 Nov 2026, 03:16 UTC

1120

Studies in scope

all four open statuses

608

Recruiting now

open to new participants

218

Lead sponsors

across recruiting studies

Top sites

New Delhi 339 Mumbai 260 Hyderabad 233 Bangalore 199 Pune 186

Trials with a site in Hyderabad

Status

Study

Lead sponsor

Phase

Enrol

Indian sites

Start

Not yet open

FLuorescent Angiography in REduction of Anastomotic Leak in Rectal Cancer Surgery

NCT07899125Rectal Cancer Patients, Rectal Cancer Surgery, Colorectal Cancer, Anastomotic Leak Rectum

Basavatarakam Indo American Cancer Hospital & Research Institute

Not applicable

610

Hyderabad

2026-11-15

Not yet open

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

NCT07838155Alzheimer Disease

DrugDonanemab

Eli Lilly and Company

Phase 4

Bangalore, Hyderabad, Kolkata, Mumbai, New Delhi, Tamil Nadu, Vellore

2026-11

Recruiting

A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

NCT07830732Haemophilia A

Novo Nordisk A/S

Phase 3

Guwahati, Kozhikode, New Delhi, Bhubaneswar, Hyderabad, Bangalore

2026-10-16

Recruiting

Comparative Study to Evaluate Microbial Versus Porcine Pancreatic Enzyme Therapy in Chronic Pancreatitis

NCT07697352Pancreatitis, Chronic, Exocrine Pancreatic Insufficiency (EPI)

Asian Institute of Gastroenterology, India

Phase 3

134

Hyderabad

2026-10-12

Recruiting

A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)

NCT07600723Pulmonary Arterial Hypertension

DrugSotatercept

Merck Sharp & Dohme LLC

Phase 4

Hyderabad, Belagavi, Chennai

2026-10-08

Recruiting

Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian Cancer

NCT07851025Epithelial Ovarian Cancer

DrugsTorvutatug samrotecan·Avastin·Bevacizumab

AstraZeneca

Phase 3

950

Ansārinagar, Bhubaneswar, Hyderabad, Mumbai, Nagpur, Nashik, New Delhi, Pune

2026-09-16

Recruiting

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

NCT07623161Myelofibrosis, Anemia

DrugElritercept

Takeda

Phase 3

324

Gurgaon, Kochi, Thiruvananthapuram, Pune, New Delhi, Rohini, Chennai, Hyderabad

2026-09-10

Recruiting

A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)

NCT07624305Renal Insufficiency, Chronic

DrugDapagliflozin

AstraZeneca

Phase 3

2,800

Aligarh, Belagavi, Bhubaneswar, Calicut, Coimbatore, Dehli, Dehradun, Hyderabad

2026-09-01

Recruiting

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

NCT07691970Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus

DrugAnifrolumab

AstraZeneca

Phase 3

1,072

Hyderabad, Kolkata, New Delhi, Pune

2026-08-31

Recruiting

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)

DrugElecoglipron

AstraZeneca

Phase 3

6,950

Belagavi, Calicut, Coimbatore, Dehradun, Delhi, Hyderabad, Jaipur, Kanpur

2026-08-24

Not yet open

EUS-Guided ATI and SWE in Individuals With Normal FibroScan

NCT07714941Non-hepatobiliary Indications

Asian Institute of Gastroenterology, India

Observational

100

Hyderabad

2026-08-20

Recruiting

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

NCT07784725Obesity or Overweight

DrugLenbelintide

AstraZeneca

Phase 3

2,500

Bhubaneswar, Coimbatore, Hyderabad, Indore, Jaipur, Jodhpur, Kochi, Kolkata

2026-08-19

Recruiting

A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India

NCT07486518Gastric Adenocarcinoma, Early Gastric Cancer

Asian Institute of Gastroenterology, India

Observational

4,000

Hyderabad

2026-08-01

Recruiting

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

NCT07497087Systemic Sclerosis

Boehringer Ingelheim

Phase 3

448

Bangalore, Bhubaneswar, Gurugram, Hyderabad, Kochi, Maharashtra, New Delhi

2026-07-27

Recruiting

Safety and Efficacy of Underwater Endoscopic Mucosal Resection for Type I Gastric Neuroendocrine Tumors Measuring 5-9 mm

NCT07728292Stomach Neuroendocrine Neoplasm

Asian Institute of Gastroenterology, India

Not applicable

Hyderabad

2026-07-17

Recruiting

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

NCT07613307Diabetes Mellitus, Type 2, Diabetes Melletus, Glucose Metabolism Disorders, Metabolic Disorders

DrugOrforglipron

Eli Lilly and Company

Phase 3

130

Agra, Hyderabad, Kanpur, Kolkata, Mumbai, Mysore, Nashik, Nellore

2026-07-15

Recruiting

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

NCT07664553Type 2 Diabetes Mellitus

DrugElecoglipron

AstraZeneca

Phase 3

600

Bangalore, Belagavi, Chennai, Coimbatore, Guntur, Hyderabad, Indore, Kochi

2026-07-08

Recruiting

Dimotec (Diosmin) 1000 mg Film Coated Tablet Fed Study

NCT07674446Healthy Volunteers

DrugsDiosmin·Diosmin-Hesperidin

Keri Pharma Hungary Kft

Phase 1

Hyderabad

2026-06-29

Recruiting

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

NCT07667803Weight Management

DrugElecoglipron

AstraZeneca

Phase 3

4,500

Bangalore, Belagavi, Bikaner, Delhi, Guntur, Hyderabad, Jaipur, Jodhpur

2026-06-29

Recruiting

Simple Non-cultured Endothelial Cell Therapy for Corneal Endothelial Dysfunction

NCT07711561Bullous Keratopathy, Corneal Endothelial Dystrophy

Singapore Eye Research Institute

Phase 1

Hyderabad

2026-06-22

Not yet open

RESTOREGI Study: Regenerative Endoscopic Stromal Therapy: Outcomes and Risk Factor Evaluation in GI Fistulas

NCT07661043Fistula, Regenerative Medicine, Stromal Vascular Fraction

Asian Institute of Gastroenterology, India

Not applicable

Hyderabad

2026-06-15

Not yet open

To Assess Dose Proportionality and Pharmacokinetic Linearity of Saninova Tablets in Healthy Participants Under Fasting Conditions

NCT07664657Bioavailability and Pharmacokinetics

Sichuan Credit Pharmaceutical Co., Ltd.

Not applicable

Hyderabad

2026-06

Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

NCT07577856Colitis, Ulcerative

DrugsJNJ-78934804·Tremfya·Guselkumab

Janssen Research & Development, LLC

Phase 3

644

Hubli, Hyderabad, Jaipur, Kochi, Mumbai (ex Bombay), Secunderabad, Surat

2026-05-23

Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

NCT07577843Crohn Disease

DrugsJNJ-78934804·Tremfya·Guselkumab

Janssen Research & Development, LLC

Phase 3

460

Hubli, Hyderabad, Jaipur, Kochi, Mumbai (ex Bombay), Secunderabad, Surat

2026-05-22

Recruiting

Conduction System Pacing Display Research System for SmartSync Pacing System Analyzer

NCT07733960Bradycardia

Medtronic Cardiac Rhythm and Heart Failure

Observational

100

Madurai, Hyderabad

2026-05-21

Recruiting

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

NCT07422480Myelodysplastic Syndrome, Anemia

DrugsElritercept·Epoetin Alfa

Takeda

Phase 3

300

Kochi, Pune, Vellore, Hyderabad, Chandigarh, Delhi

2026-05-21

Active, closed

Biological Optimization Versus Standard Care in Post-POEM Achalasia Patients (BIO-POEM)

NCT07620899Achalasia Cardia, GERD (Gastroesophageal Reflux Disease)

Asian Institute of Gastroenterology, India

Not applicable

166

Hyderabad

2026-05-20

Recruiting

Composite Index for Outcome Burden in Acute Cholangitis

NCT07667166Acute Cholangitis, Biliary Drainage

Asian Institute of Gastroenterology, India

Observational

514

Hyderabad

2026-04-20

Recruiting

Regenerative Endoscopy in Refractory Perianal Crohn's Disease

NCT07652632Crohn Disease (CD), Perianal Crohns Disease

Asian Institute of Gastroenterology, India

Not applicable

Hyderabad

2026-04-20

Recruiting

Pancreatic Enzyme Replacement in Acute Necrotizing Pancreatitis

NCT07441824Acute Necrotizing Pancreatitis, Pancreatic Exocrine Insufficiency

Asian Institute of Gastroenterology, India

Phase 3

140

Guwahati, Hyderabad, Kolkata

2026-04-10

Recruiting

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe

DrugZotemtegrast

Eli Lilly and Company

Phase 2

1,431

Allahabād, Belagavi, Belgavi, Hyderabad, Jaipur, Kochi, Lucknow, Mumbai

2026-03-26

Recruiting

A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis

NCT07169695Moderate to Severe Vernal Keratoconjunctivitis

DrugCiclosporin

Laboratoires Thea

Phase 2

120

Kolkata, Ahmedabad, Bangalore, Hyderabad, Jaipur, Patna, Pune, Surat

2026-03-24

Recruiting

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease

NCT07355296Proteinuric Kidney Diseases

DrugApecotrep

Boehringer Ingelheim

Phase 2

132

Ahmedabad, Bhubaneswar, Hyderabad, Kozhikode, Lucknow, Pune, Varanasi

2026-03-23

Recruiting

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

NCT07361510Non-Small Cell Lung Cancer (NSCLC)

DrugsPumitamig·Pembrolizumab

Bristol-Myers Squibb

Phase 3

750

Visakhapatnam, Goraj, Mumbai, Nagpur, Dwarka, Hyderabad, Delhi, Pune

2026-03-12

Recruiting

Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD

NCT07431983Ulcerative Colitis (UC), Crohns Disease

Asian Institute of Gastroenterology, India

Observational

200

Hyderabad

2026-03-01

Recruiting

A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis

NCT07171983Rheumatoid Arthritis

Bristol-Myers Squibb

Phase 1

Hyderabad, Ahmedabad, Bangalore, Mysuru, Nagpur, Pune, Bhubaneswar, Secunderabad

2026-02-27

Recruiting

Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU

NCT07399054Stress Ulcers, Reflux Episodes

DrugEsomeprazole

Asian Institute of Gastroenterology, India

Observational

Hyderabad

2026-02-23

Recruiting

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

NCT07220083Focal Segmental Glomerulosclerosis

DrugApecotrep

Boehringer Ingelheim

Phase 3

286

Ahmedabad, Bhubaneswar, Bikaner, Chennai, Dehradun, Delhi, Hyderabad, Kozhikode

2026-02-16

Recruiting

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT07363694Moderate to Severe Chronic Obstructive Pulmonary Disease

Pfizer

Phase 2/3

1,156

Belagavi, Thane, New Delhi, Jaipur, Coimbatore, Hyderabad, Dehradun, Kolkata

2026-02-11

Recruiting

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

NCT07392190Overweight, Obesity

DrugEloralintide

Eli Lilly and Company

Phase 3

900

Allahabād, Bangalore, Chennai, Hyderabad, Jaipur, Kanpur, Kolhāpur, Mysore

2026-02-10

Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

NCT07321886Obesity, Overweight

DrugEloralintide

Eli Lilly and Company

Phase 3

1,980

Guntur, Guwahati, Hyderabad, Mandya, Mumbai, Mysore, Nagpur, Nashik

2026-02-06

Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

NCT07431281Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal Cancer

DrugsSonesitatug Vedotin·Zolbetuximab·Rilvegostomig·Leucovorin

AstraZeneca

Phase 3

2,130

Ahmedabad, Bhubaneswar, Hyderabad, Kolkata, Mohali, Mumbai, New Delhi, Varanasi

2026-02-03

Recruiting

A Randomized Controlled Trial Comparing Underwater Versus Conventional Preventive Coagulation for Intraprocedural Vessel Management During Peroral Endoscopic Myotomy

NCT07575295Vessel Puncture Site Reaction

Asian Institute of Gastroenterology, India

Observational

120

Hyderabad

2026-02-01

Recruiting

Post-marketing Phase 4 Safety & Tolerability Study of Breztri aerosphereTM in Indian Patients With Chronic Obstructive Pulmonary Disease

NCT06531798Moderate to Severe COPD

AstraZeneca

Phase 4

166

Bangalore, Dalgate, Drugjan, Hyderabad, Lucknow, Nagpur, New Delhi

2026-01-20

Recruiting

A Single Center Evaluation of AI Enabled SureForm Robotic Stapler (SureformTM) Compared to Conventional Stapler for Colorectal Cancer Procedures

NCT07371832Colorectal Cancer

Asian Institute of Gastroenterology, India

Observational

200

Hyderabad

2026-01-19

Recruiting

Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial

NCT07731542Functioanl Dyspepsia

DrugVonoprazan

Asian Institute of Gastroenterology, India

Not applicable

192

Hyderabad

2026-01-10

Recruiting

Neural Sensitisation and Neuropsychological Alterations in Painful Chronic Pancreatitis

NCT07707609Chronic Pancreatitis, Pain Management

Asian Institute of Gastroenterology, India

Observational

200

Hyderabad

2026-01-06

Recruiting

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

NCT07063745Metastatic Non-small Cell Lung Cancer With MTAP Deletion

DrugsNavlimetostat·Nab-paclitaxel·Pemetrexed·Paclitaxel

Bristol-Myers Squibb

Phase 2/3

590

Bangalore, Bengaluru, Mumbai, Nashik, New Delhi, Varanasi, Hyderabad

2026-01-02

Not yet open

Combination Therapy With Infliximab and Tofacitinib for Acute Severe Ulcerative Colitis - CINTO Trial

NCT07297069Acute Severe Ulcerative Colitis

DrugsInfliximab·Tofacitinib

Asian Institute of Gastroenterology, India

Phase 2

Hyderabad

2026-01-01

Recruiting

To Evaluate Early (2-Week) vs. Standard (4-Week) Metal Stent Removal Following Endoscopic Ultrasound Guided WON Drainage

NCT07307248Walled Off Necrosis

Asian Institute of Gastroenterology, India

Not applicable

408

Hyderabad

2025-12-25

Recruiting

A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks

NCT06953986GERD

DrugsVonoprazan·Esomeprazole

Asian Institute of Gastroenterology, India

Not applicable

414

Hyderabad

2025-12-20

Active, closed

Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease

NCT06851806Respiratory Syncytial Virus (RSV)

AstraZeneca

Not applicable

Hyderabad, Jhānsi, Kanpur, Kolkata, Mysore, Nagpur, Pune, Vidyanagar, Hubballi

2025-12-10

Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

NCT07221253Biliary Tract Cancer

DrugsGemcitabine/Cisplatin·Rilvegostomig·Durvalumab

AstraZeneca

Phase 3

1,100

Delhi, Hyderabad, Kolhāpur, Kolkata, Mumbai, Nashik, Surat

2025-12-04

Recruiting

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

NCT06937229Alzheimer Disease, Agitation

DrugsKarX-EC·KarXT

Bristol-Myers Squibb

Phase 3

650

Ahmedabad, Hyderabad, Varanasi, Kolkata, Delhi, New Delhi

2025-12-02

Recruiting

A COMBINATION OF RECTAL INDOMETHACIN AND COLD WATER EXPOSURE OF THE AMPULLA AFTER ERCP IS SUPERIOR TO RECTAL INDOMETHACIN ALONE IN REDUCING THE INCIDENCE OF POST-ERCP PANCREATITIS -RCT

NCT07574970Pancreas Disease

Asian Institute of Gastroenterology, India

Observational

150

Hyderabad

2025-12-01

Recruiting

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

NCT07241390Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease

DrugOrforglipron

Eli Lilly and Company

Phase 3

7,140

Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Guntur, Hubli, Hyderabad, Kanpur

2025-12-01

Recruiting

Prospective Comparison of the Carbon Footprint of EUS vs MRCP for Evaluation of Suspected Choledocholithiasis

NCT07283185Choledocholithiasis

Asian Institute of Gastroenterology, India

Observational

200

Hyderabad

2025-12-01

Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

NCT07225504Secondary Progressive Multiple Sclerosis (SPMS)

DrugRemibrutinib

Novartis Pharmaceuticals

Phase 3

1,275

Gurugram, Mangalore, Kochi, New Delhi, Chandigarh, Vellore, Hyderabad

2025-11-11

Recruiting

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

NCT07186101Ulcerative Colitis

DrugsZotemtegrast·Mirikizumab

Eli Lilly and Company

Phase 2

252

Ahmedabad, Chennai, Coimbatore, Hubli, Hyderabad, New Delhi, Pune, Rajkot

2025-11-10

Active, closed

A Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

NCT07076121Pancreatic Ductal Adenocarcinoma

DrugsNavlimetostat·Abraxane·Nab-paclitaxel·Gemcitabine

Bristol-Myers Squibb

Phase 2/3

470

Kochi, Mumbai, New Delhi, Bhubaneswar, Hyderabad, Varanasi, Kolkata

2025-10-23

Recruiting

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

NCT07165028Metabolic Dysfunction-Associated Steatotic Liver Disease

DrugsRetatrutide·Tirzepatide

Eli Lilly and Company

Phase 3

4,500

Ahmedabad, Bhubaneswar, Chandigarh, Ernākulam, Guntur, Hyderabad, Jaipur, Kochi

2025-10-15

Recruiting

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

NCT07196722Crohn Disease

DrugIcotrokinra

Janssen Research & Development, LLC

Phase 2/3

1,092

Bangalore, Bengaluru, Bhubaneswar, Gurugram, Hyderabad, Jaipur, Kochi, Ludhiana

2025-10-03

Active, closed

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

NCT07196748Colitis, Ulcerative

DrugIcotrokinra

Janssen Research & Development, LLC

Phase 3

896

Bangalore, Bengaluru, Bhubaneswar, Ernākulam, Gurugram, Hyderabad, Jaipur, Ludhiana

2025-10-01

Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT06979336Ulcerative Colitis

Genentech, Inc.

Phase 2

224

Hyderabad, Rajkot, Nagpur, Jaipur, Kolkata

2025-09-29

Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

NCT06926868Breast Neoplasms

DrugsIza-bren·Nab-paclitaxel·Capecitabine·Gemcitabine

Bristol-Myers Squibb

Phase 2/3

600

Mumbai, Nagpur, New Delhi, Chennai, Hyderabad, Varanasi

2025-09-11

Active, closed

A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

NCT07004972Symptomatic Obstructive Hypertrophic Cardiomyopathy

DrugMavacamten

Bristol-Myers Squibb

Phase 4

Hyderabad, Ahmedabad, Surat, Gurgaon, Belagavi, Mangalore, Ernākulam, Kottayam

2025-09-04

Recruiting

A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in India

NCT07157423Severe Postpartum Haemorrhage

DrugRecombinant factor VIIa

Novo Nordisk A/S

Phase 4

Belagavi, Mysore, Kozhikode, Mumbai, New Delhi, Jaipur, Udaipur, Hyderabad

2025-08-26

Recruiting

Effect of Weight Loss From ESG Plus Lifestyle Changes vs. Lifestyle Changes Alone in Sleep Apnea Patients

NCT07082608OSA - Obstructive Sleep Apnea

Asian Institute of Gastroenterology, India

Not applicable

Hyderabad

2025-08-19

Recruiting

A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

NCT07141004Arthritis, Psoriatic

DrugsTremfya·Guselkumab

Johnson & Johnson Private Limited

Phase 4

100

Ahmedabad, Chandigarh, Chennai, Gorakhpur, Hyderabad, Mumbai, New Delhi, Patna

2025-08-12

Active, closed

Parent Study: A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism Sub-study: A Follow-up Substudy After Completion of the BaxPA Main Study.

NCT07007793Primary Hyperaldosteronism

DrugBaxdrostat

AstraZeneca

Phase 3

212

Belagavi, Delhi, Hyderabad, Kolkata, Mumbai

2025-08-07

Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

NCT06952803Prostate Cancer

DrugsPrednisolone/prednisone·Saruparib·Abiraterone

AstraZeneca

Phase 3

700

Ansārinagar, Babgalore, Calicut, Delhi, Hyderabad, Kannur, Kanpur, Mumbai

2025-08-06

Not yet open

Personalized Education and Pain Response in Chronic Pancreatitis

NCT04654377Chronic Pancreatitis, Pain Syndrome, Depression, Anxiety

Asian Institute of Gastroenterology, India

Not applicable

114

Hyderabad

2025-08-01

Recruiting

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

NCT06911502Follicular Lymphoma

DrugsPrednisone/Prednisolone·Golcadomide·Bendamustine·Vincristine

Celgene

Phase 3

400

Bengaluru, Mumbai, New Delhi, Hyderabad

2025-07-28

Recruiting

A Study Comparing Transperineal Ultrasound, Magnetic Resonance Imaging, Endoscopic Ultrasound, and Examination Under Anesthesia to Detect and Classify Perianal Fistulas in Patients With Crohn's Disease or Fistulas of Unknown Cause

NCT07794410Crohn Disease (CD), Cryptoglandular Perianal Fistula

Asian Institute of Gastroenterology, India

Not applicable

Hyderabad

2025-07-25

Recruiting

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

NCT06758401Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)

DrugsSigvotatug vedotin·Pembrolizumab

Pfizer

Phase 3

714

Bengaluru, Mumbai, Pune, Thane, New Delhi, Hyderabad

2025-07-23

Recruiting

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

NCT06929273Bipolar Disorder Type I With Mania

DrugsValproate·Lamotrigine·Lithium·KarXT

Bristol-Myers Squibb

Phase 3

450

Vadodara, Belagavi, Kozhikode, Ludhiana, Madurai, Hyderabad, Kolkata, Mangalore

2025-07-18

Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

NCT06976216Alzheimer's Disease

DrugsKarX-EC·KarXT

Bristol-Myers Squibb

Phase 3

586

Bengaluru, Hyderabad, Varanasi, Kolkata

2025-07-14

Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

NCT07011732Alzheimer Disease

DrugsKarX-EC·KarXT

Bristol-Myers Squibb

Phase 3

426

Ahmedabad, Hyderabad, Varanasi, Kolkata, Delhi, New Delhi

2025-07-10

Active, closed

A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

NCT06981078Chronic Obstructive Pulmonary Disease

DrugVerekitug

Upstream Bio Inc.

Phase 2

666

Hyderabad, Nellore, Vijayawada, Gurgaon, Rohtak, Kolhāpur, Nagpur, New Delhi

2025-07-02

Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

NCT06966700Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms

DrugsEpirubicin·Adriamycin·Xeloda·Paraplatin

Merck Sharp & Dohme LLC

Phase 3

2,400

Hyderabad

2025-06-30

Recruiting

A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy

NCT06979362Heart Failure

DrugCDR132L

Novo Nordisk A/S

Phase 2

200

Vadodara, Nagpur, New Delhi, New Dehli, Vijayawada, Chennai, Hyderabad, Dehradun

2025-06-27

Recruiting

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

NCT07082738Chronic Obstructive Pulmonary Disease (COPD)

AstraZeneca

Phase 2

987

Belagavi, Coimbatore, Dehradun, Delhi, Dwārka, Hyderabad, Kochi, Mumbai

2025-06-27

Active, closed

A Warning Red Flag Classification System to Predict Risk of Vasovagal Event During Office Hysteroscopy

NCT07030218Vasovagal Syncope (VVS), Presyncope

Tanvir Hospital

Observational

100

Hyderabad

2025-06-20

Recruiting

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

NCT06951711Bipolar Disorder Type I With Mania or Mania With Mixed Features

DrugKarXT

Bristol-Myers Squibb

Phase 3

274

Visakhapatnam, Vadodara, Belagavi, Kozhikode, Ludhiana, Hyderabad, Kolkata

2025-06-13

Active, closed

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

NCT07037277HEPATITIS C VIRUS CHRONIC INFECTION, Hepatitis C, Chronic, Hepatitis C Virus Infection, Hepatitis C

DrugSofosbuvir-Velpatasvir

Atea Pharmaceuticals, Inc.

Phase 3

880

Hyderabad, Patna, Rajkot, Surat, Shimla, Belagavi, Kochi, Mumbai

2025-06-02

Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative

DrugsSPY001·SPY002·SPY003

Spyre Therapeutics, Inc.

Phase 2

645

New Delhi, Hyderabad, Jaipur, Kochi, Sūrat

2025-05-27

Recruiting

A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

NCT06962800Primary Membranous Nephropathy

DrugsFelzartamab·Tacrolimus

Biogen

Phase 3

180

Hyderabad, Bangalore, Pune, New Delhi, Lucknow, Varanasi, Kolkata, Chandigarh

2025-05-22

Recruiting

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

NCT06935357Immunoglobulin A Nephropathy (IgAN)

DrugFelzartamab

Biogen

Phase 3

454

Hyderabad, Raipur, Ahmedabad, Nadiād, Bangalore, Kozhikode, Trivandrum, Mumbai

2025-05-08

Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

NCT06921785Hepatocellular Carcinoma

DrugsRilvegostomig·Tremelimumab·Atezolizumab·Bevacizumab

AstraZeneca

Phase 3

1,220

Ahmedabad, Bangalore, Binnāguri, Dehradun, Delhi, Hyderabad, Mumbai, Nashik

2025-05-06

Recruiting

From Exclusion to Inclusion: Analysing Follow-up Discontinuity in Breast Cancer

NCT06927102Breast Carcinoma

Basavatarakam Indo American Cancer Hospital & Research Institute

Observational

1,500

Hyderabad

2025-05-01

Recruiting

Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM

NCT06955520GERD

DrugsVonoprazan·Esomeprazole

Asian Institute of Gastroenterology, India

Not applicable

300

Hyderabad

2025-04-30

Recruiting

Hybrid Endoscopic Stricturotomy Plus Balloon Dilation Versus Stricturotomy Alone for Short Crohn's Disease Strictures

NCT06958159Crohn Disease (CD)

Asian Institute of Gastroenterology, India

Not applicable

Hyderabad

2025-04-29

Recruiting

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

NCT06875310Carcinoma, Non-Small-Cell Lung

DrugsAdagrasib·Pemetrexed·Keytruda·Cisplatin

Mirati Therapeutics Inc.

Phase 3

630

Visakhapatnam, Ahmedabad, Thiruvananthapuram, Mumbai, New Delhi, Bhubaneswar, Madurai, Hyderabad

2025-04-24

Recruiting

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

NCT05066217Lennox Gastaut Syndrome

DrugClemizole HCl

Epygenix

Phase 3

260

Hyderabad, Ahmedabad, Surat, Calicut

2025-04-09

Not yet open

Evaluate the Detection of Retained Gastric Contents and Assess Safety Using the Flower Capsule Endoscopy in Healthy Individuals and GLP-1 Receptor Agonist Users

NCT06927401Endoscopy, Digestive System, GLP1-R-related Disease

Asian Institute of Gastroenterology, India

Not applicable

Hyderabad

2025-04-08

Recruiting

Normal Values of Ambulatory 24-hour Oesophageal pH-impedance Monitoring in an Indian Cohort of Participants

NCT06928350GERD (Gastroesophageal Reflux Disease)

Asian Institute of Gastroenterology, India

Observational

Hyderabad

2025-04-01

Recruiting

Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication

NCT06959368Helicobacter Pylori Infection

Asian Institute of Gastroenterology, India

Phase 4

484

Hyderabad

2025-03-25

Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

NCT06677060Heart Failure

DrugBaxdrostat/dapagliflozin

AstraZeneca

Phase 3

11,300

Ahmedabad, Ajmer, Bangalore, Belagavi, Dehradun, Delhi, Gūrgaon, Hyderabad

2025-03-14

Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

NCT06742723Chronic Kidney Disease and Hypertension

DrugBaxdrostat/dapagliflozin

AstraZeneca

Phase 3

5,000

Bangalore, Belagavi, Hyderabad, Kolkata, Madurai, Mumbai, New Delhi, Pune

2025-03-03

Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

NCT06764875HER2-positive Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

DrugsRilvegostomig·Trastuzumab deruxtecan·Trastuzumab·Adrucil

AstraZeneca

Phase 3

840

Ansārinagar, Bangalore, Delhi, Hyderabad, Kolkata, Mumbai, Varanasi

2025-03-01

Recruiting

Incidence of Splanchnic Venous Thrombosis in Acute Pancreatitis and it's Correlation With Severity of Pancreatitis

NCT07322978Acute Pancreatitis

Asian Institute of Gastroenterology, India

Observational

500

Hyderabad

2025-02-27

Active, closed

A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

NCT06878404Arthritis, Psoriatic

DrugIcotrokinra

Janssen Research & Development, LLC

Phase 3

552

Ahmedabad, Bhubaneswar, Hyderabad, Kolkata, Mumbai, Mysuru, New Delhi, Noida

2025-02-21

Recruiting

A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With Cirrhosis

NCT06808074Hepatic Encephalopathy, Cirrhosis, Ventilator Associated Pneumonia (VAP)

DrugAmikacin

Asian Institute of Gastroenterology, India

Phase 4

162

Hyderabad

2025-02-12

Active, closed

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

NCT06744920Generalized Myasthenia Gravis

DrugRemibrutinib

Novartis Pharmaceuticals

Phase 3

180

Gurugram, Mangalore, Nashik, New Delhi, Ludhiana, Vellore, Hyderabad, Lucknow

2025-02-07

Recruiting

RCT of EFTR Versus STER for GIST Treatment

NCT07411118Small Size Gastrointestinal Stromal Tumors, GIST

Chinese University of Hong Kong

Not applicable

136

Hyderabad

2025-02-01

Recruiting

Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors

NCT06549673Portal Hypertension, Cirrhosis, Varices, Esophageal

Chinese University of Hong Kong

Observational

375

Hyderabad, New Delhi

2025-01-20

Recruiting

LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk

NCT06765863Very Preterm Infant, Very Low Birthweight

Harvard School of Public Health (HSPH)

Not applicable

776

Ballary, Belagavi, Davangere, Hyderabad

2025-01-16

By invitation

CreNeuroS™️CNS Fish Oil Plus Softgels Compared to Vascepa® Capsules and Deplin® Capsules in a Pharmacokinetic, Single Dose Evaluation on Healthy Adult Human Subjects Under Fasting Conditions

NCT06758778Bioavailability

Sichuan Credit Pharmaceutical Co., Ltd.

Not applicable

Hyderabad

2025-01-03

Recruiting

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

NCT06679101Multiple Myeloma, Newly Diagnosed Multiple Myeloma

DrugsBelantamab mafodotin·Daratumumab·Lenalidomide·Dexamethasone

GlaxoSmithKline

Phase 3

520

Ahmedabad, Bangalore, Hyderabad, Kolkata, Pune, Sushrut Hospital and Research

2024-12-16

Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

NCT06750094Colorectal Neoplasms

DrugsLeucovorin calcium/Levoleucovorin·Amivantamab·Erbitux·Avastin

Janssen Research & Development, LLC

Phase 3

700

Delhi, Hyderabad, Kolkata, Mumbai, New Delhi, Pune, Varanasi, Vellore

2024-12-12

Recruiting

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

NCT06717698Chronic Kidney Disease

DrugSemaglutide

Novo Nordisk A/S

Phase 2

465

Guntur, Bengaluru, Kozhikode, Jaipur, Hyderabad

2024-12-02

Recruiting

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis

DrugEfruxifermin

Akero Therapeutics, Inc

Phase 3

2,150

Hyderabad, Surat, Vadodara, Mysore, Thiruvananthapuram, Mumbai, Nagpur, Pune

2024-10-04

Active, closed

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06417814Metastatic Non-small Cell Lung Cancer

DrugsTagrisso·Dato-DXd·Osimertinib·Pemetrexed

AstraZeneca

Phase 3

768

Hyderabad, Kolhāpur, Mumbai, Namakkal, Pune, Ranchi, Thane, Varanasi

2024-10-04

By invitation

Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma

NCT06609239Asthma

DrugLunsekimig

Sanofi

Phase 2

900

Calicut, Hyderabad, Kanpur, Nagpur, Pune

2024-09-30

Recruiting

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

NCT06585787Alzheimer Disease

DrugKarXT

Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 3

406

Chhatrapati Sambhajinagar, Nagpur, Chandigarh, Ajmer, Hyderabad, Kolkata, Varanasi

2024-09-26

Recruiting

Comparing Diagnostic Accuracy of High-end Intestinal Ultrasound Versus Mid-end Ultrasound With Tandem Ileo-colonoscopy in Inflammatory Bowel Disease : a Paired, Validating Confirmatory Study

NCT06938295Inflammatory Bowel Disease (IBD)

Asian Institute of Gastroenterology, India

Not applicable

500

Hyderabad

2024-09-14

Recruiting

Safety, Efficacy and Tolerability of Bowel Preparation and Colonoscopy in Patient With CHD, CKD and CLD

NCT06874036Colon Disease

Asian Institute of Gastroenterology, India

Observational

Hyderabad

2024-08-10

By invitation

Long-term Safety and Tolerability of BHV-7000

NCT06443463Focal Epilepsy

DrugOpakalim

Biohaven Therapeutics Ltd.

Phase 2

660

Hyderabad, Mangalore, Mumbai, Nagpur, New Delhi

2024-07-30

Recruiting

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

NCT06282575Biliary Tract Cancer

DrugsZanidatamab·Durvalumab·Gemcitabine·Cisplatin

Jazz Pharmaceuticals

Phase 3

286

Belagavi, Mumbai, Nashik, Hyderabad, Varanasi, New Delhi

2024-07-19

Recruiting

Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries- PreTerm

NCT06240715Preterm, Infant Death

Nemours Children's Clinic

Not applicable

800

Belagavi, Chandrapur, Nagpur, Pune, Wardha, Jaipur, Hyderabad

2024-07-01

Recruiting

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

NCT06463587Generalized Myasthenia Gravis

DrugCladribine

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Phase 3

264

Hyderabad, Bangalore, Mangalore, Nashik, Pune

2024-06-25

Recruiting

A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)

NCT06455449Polymyositis, Dermatomyositis

AstraZeneca

Phase 3

240

Ahmedabad, Bangalore, Dehradun, Delhi, Gurugram, Hyderabad, Kolkata, Lucknow

2024-06-20

Recruiting

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

NCT06056297Neutropenia

X4 Pharmaceuticals

Phase 3

176

Patna, Surat, Udaipur, Hyderabad

2024-06-06

Recruiting

Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

NCT06394232Retinal Disease, Macular Degeneration, Age-Related Macular Degeneration, Geographic Atrophy

DrugTacrolimus

Eyestem Research Pvt. Ltd.

Phase 1/2

Jālna, Delhi, Hyderabad

2024-06-04

Active, closed

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

NCT06309966Focal Epilepsy

DrugOpakalim

Biohaven Therapeutics Ltd.

Phase 2/3

390

Hyderabad, Mangalore, Mumbai, Nagpur, New Delhi

2024-05-13

Recruiting

Comparative Assessment of Esophagitis in Cases With and Without Esophageal Motility Disorders: A Prospective Study

NCT06835374Esophageal Diseases

Asian Institute of Gastroenterology, India

Not applicable

200

Hyderabad

2024-05-11

Recruiting

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT06350097Non-small Cell Lung Cancer

DrugsDato-DXd·Osimertinib

AstraZeneca

Phase 3

582

Bangalore, Delhi, Hyderabad, Kolkata, Mysuru, Nagpur, Nashik, New Delhi

2024-04-29

Active, closed

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

NCT06256432Hepatorenal Syndrome, Liver Cirrhosis, Acute Kidney Injury, Ascites Hepatic

DrugsAmbrisentan·Terlipressin

Noorik Biopharmaceuticals AG

Phase 2

Bangalore, Mumbai, New Delhi, Hyderabad, Kanpur, Lucknow

2024-04-17

Recruiting

Prophylactic EUS-guided Gastroenterostomy in Advanced Periampullary Cancers

NCT05994521Cancer Gi

McGill University Health Centre/Research Institute of the McGill University Health Centre

Not applicable

110

Hyderabad

2024-04-09

Active, closed

Role of Intestinal Ultrasound in Treat to Target Strategy in the Management of Inflammatory Bowel Disease : the IUS-TTT Study

NCT06534216Crohn Disease, Ulcerative Colitis

Asian Institute of Gastroenterology, India

Observational

100

Hyderabad

2024-04-05

Active, closed

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

NCT06268873Chronic Kidney Disease and Hypertension

DrugBaxdrostat/dapagliflozin

AstraZeneca

Phase 3

2,554

Bangalore, Belagavi, Calicut, Chennai, Coimbatore, Dehradun, Hyderabad, Kolkata

2024-03-29

Recruiting

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

NCT06256588Neoplasms, Head and Neck

DrugDostarlimab

GlaxoSmithKline

Phase 3

864

Mumbai, Pune, Bengaluru, Bhubaneswar, Gūrgaon, Hyderabad, Nashik, Nehru Nagar Belagavi Karnataka 590010

2024-03-21

Active, closed

A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer

NCT06348199Non-small Cell Lung Cancer Stage IV

DrugsKeytruda·Pembrolizumab

Samsung Bioepis Co., Ltd.

Phase 3

555

Bangalore, Bhubaneswar, Erandwane, Hyderabad, Jaipur, Mumbai, Sūrat, Udaipur

2024-03-12

Active, closed

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

NCT06346392Gastric Cancer, Gastroesophageal Junction Cancer

DrugsSonesitatug Vedotin·Ramucirumab·Trifluridine/Tipiracil·Apatinib

AstraZeneca

Phase 3

594

Ahmedabad, Hyderabad, Mumbai, New Delhi

2024-03-04

Recruiting

Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)

NCT06189209Triple Negative Breast Cancer (TNBC)

Rhizen Pharmaceuticals SA

Phase 2

Vijayawada, Bangalore, Mumbai, Pune, Madurai, Hyderabad, Kolkata

2024-03-04

Active, closed

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

NCT05827081Early Breast Cancer

DrugsLeuprolide·Goserelin·Exemestane·Ribociclib

Novartis Pharmaceuticals

Phase 3

1,466

Hyderabad, Bangalore, Mumbai, Pune, New Delhi, Bhubaneswar, Chennai, Kolkata

2024-02-28

Recruiting

Study of Olverembatinib (HQP1351) in Patients With CML-CP

NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase

DrugsBosutinib·Olverembatinib

Ascentage Pharma Group Inc.

Phase 3

333

Bangalore, Haryāna, Hyderabad, Kolkata, New Delhi, Pune, Thiruvananthapuram

2024-02-05

Recruiting

Cognitive Level Enhancement Through Vision Exams and Refraction

NCT05458323Refractive Errors

Queen's University, Belfast

Not applicable

820

Hyderabad

2024-01-18

Recruiting

A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)

NCT06412250Cardiovascular Diseases

Translumina Therapeutics Pvt Ltd.

Observational

2,000

Ahmedabad, Bangalore, Bathinda, Chandigarh, Delhi, Gurugram, Hyderabad, Jabalpur

2024-01-10

Active, closed

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

NCT06141486Multiple Sclerosis

DrugFrexalimab

Sanofi

Phase 3

943

Bengaluru, Hyderabad, New Delhi, Shimla

2023-12-27

Active, closed

Spectacle Films Utilising S.T.O.P.® Technology for Slowing Down Myopia Progression in Children

NCT06137560Myopia

nthalmic Pty Ltd

Not applicable

210

Surat, Hyderabad

2023-12-22

Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

NCT06119581Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

DrugsOlomorasib·Pemetrexed·Cisplatin·Carboplatin

Eli Lilly and Company

Phase 3

1,264

Ahmedabad, Belagavi, Bengaluru, Bhubaneswar, Coimbatore, Hyderabad, Karad, Kolhāpur

2023-12-21

Recruiting

A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy

NCT06129864Locally Advanced Head and Neck Squamous Cell Carcinoma

DrugVolrustomig

AstraZeneca

Phase 3

1,145

Bengaluru, Hyderabad, Jaipur, Kanpur, Kochi, Kolkata, Lucknow, Madurai

2023-12-14

Active, closed

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

NCT06141473Multiple Sclerosis

DrugsCholestyramine·Activated Charcoal·Teriflunomide·Frexalimab

Sanofi

Phase 3

1,655

Chandigarh, Hyderabad, Kochi, Nagpur, Nashik, New Delhi, Shimla, Thiruvananthapuram

2023-12-13

Active, closed

A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia

NCT07052006Myelodysplastic Syndrome, Anemia in Myelodysplastic Syndromes

Halia Therapeutics, Inc.

Phase 2

Ahmedabad, Kannur, Visakhapatnam, Kolhāpur, Dehradun, Madurai, Hyderabad, Kolkata

2023-12-09

Recruiting

POEM-F for Achalasia International Study

NCT06042127Achalasia

Chinese University of Hong Kong

Not applicable

Chandigarh, Hyderabad, Mumbai, Pune

2023-12-01

Recruiting

Standard Versus Oesophago-gastric Junction Complex Myotomy for Treatment naïve Type 2 Achalasia Patients

NCT06870630Esophageal Diseases

Asian Institute of Gastroenterology, India

Not applicable

158

Hyderabad

2023-11-29

Active, closed

The Use of MicroRNAs Dysregulation as Potential Biomarkers for Effective Diagnosis of Endometriosis

NCT06168097Endometriosis

Asian Institute of Gastroenterology, India

Not applicable

200

Hyderabad

2023-11-15

Active, closed

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

NCT05925803Systemic Sclerosis, Scleroderma

AstraZeneca

Phase 3

314

Ahmedabad, Delhi, Gurugram, Hyderabad, Kolkata, Mumbai, Mysuru, New Delhi

2023-11-08

Not yet open

Ovary Syndrome for Efficient Diagnosis and Targeted Therapy

NCT06102629Polycystic Ovary Syndrome

Asian Institute of Gastroenterology, India

Not applicable

200

Hyderabad

2023-11-05

Recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

NCT05862012Relapsed/Refractory Multiple Myeloma

Ichnos Sciences SA

Phase 1

200

Gandhinagar, Bangalore, Pune, Hyderabad

2023-11-01

Active, closed

A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.

NCT05984277Metastatic Non-small Cell Lung Cancer

DrugsVolrustomig·Pemetrexed·Paclitaxel·Carboplatin

AstraZeneca

Phase 3

895

Bengaluru, Hyderabad, Kolkata, Mysuru, Nagpur, Varanasi

2023-10-24

Recruiting

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

NCT05755386IC-MPGN

DrugIptacopan

Novartis Pharmaceuticals

Phase 3

106

Bangalore, Nagpur, Pune, New Delhi, Hyderabad

2023-10-02

Recruiting

Application of Machine Learning Models to Reduce Need for Diagnostic EUS or MRCP in Patients With Intermediate Likelihood of Choledocholithiasis

NCT06066372Choledocholithiasis

Asian Institute of Gastroenterology, India

Observational

1,000

Hyderabad

2023-10-01

Recruiting

Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy

NCT05514340Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia, Neonatal Encephalopathy

DrugSovateltide

Pharmazz, Inc.

Phase 2

Mangalore, Ludhiana, Hyderabad, Kanpur

2023-09-06

Active, closed

S.T.O.P.® Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children

NCT05243836Myopia

nthalmic Pty Ltd

Not applicable

441

Hyderabad

2023-08-04

Recruiting

Clinical Application of Artificial Intelligence in New Borns With Cleft Lip and Palate

NCT06970158Congenital Disorder, Cleft Lip Palate

University Hospital, Basel, Switzerland

Not applicable

Chennai, Hyderabad

2023-08-01

Recruiting

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

NCT05855200Colonic Neoplasms, Neoplasms, Colon

DrugsCapeox·Dostarlimab·Folfox

GlaxoSmithKline

Phase 3

892

Bengaluru, Ludhiana, Belagavi, Hyderabad, Nashik, Pune

2023-08-01

Recruiting

Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)

NCT05980949Psychosis Associated With Alzheimer's Disease

DrugKarXT

Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 3

1,000

Nagpur, Chandigarh, Ajmer, Hyderabad, Kolkata, Varanasi

2023-07-11

Active, closed

A Study of Zigakibart in Adults With IgA Nephropathy

NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy

DrugZigakibart

Novartis Pharmaceuticals

Phase 3

383

Hyderabad, Chandigarh, Faridabad, Bengaluru, Trivandrum, Jaipur, Vellore, Lucknow

2023-07-06

Active, closed

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT05878769Chronic Obstructive Pulmonary Disease

Hoffmann-La Roche

Phase 3

2,000

Hyderabad, Ahmedabad, Faridabad, Hubli, Nagpur, Pune, Ajmer, Jaipur

2023-06-28

Active, closed

A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus

NCT05672576Lupus Erythematosus, Systemic

DrugCenerimod

Viatris Innovation GmbH

Phase 3

451

Ahmedabad, Chennai, Hyderabad, Kolkata, Nagpur, Nashik, New Delhi, Pune

2023-06-26

Active, closed

A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India

NCT05891249Anemia

DrugsReblozyl·Luspatercept

Bristol-Myers Squibb

Phase 4

Ahmedabad, New Delhi, Kolkata, Assam, Bangalore, Chandigarh, Delhi, Hyderabad

2023-06-05

Active, closed

Validating Artificial Intelligence Effectiveness Defined Lung Nodule Malignancy Score in Patients With Pulmonary Nodule.

NCT05817110Lung Malignancy

AstraZeneca

Observational

712

Gurugram, New Delhi, Hyderabad, Bangalore, Chennai, Kolkata, Mumbai, Pune

2023-04-20

Recruiting

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting

Weill Medical College of Cornell University

Not applicable

2,300

Coimbatore, Hyderabad

2023-04-17

Recruiting

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

NCT05774951Breast Cancer, Early Breast Cancer

DrugsCamizestrant·Tamoxifen·Exemestane·Anastrozole

AstraZeneca

Phase 3

4,300

Bangalore, Belagavi, Bhubaneswar, Hubli, Hyderabad, Jaipur, Kolkata, Mumbai

2023-03-31

Active, closed

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

NCT05669755Cardiovascular Disease

DrugsCagrilintide·Semaglutide

Novo Nordisk A/S

Phase 3

7,101

Guntur, Hyderabad, Vijayawada, Guwahati, Raipur, Ahmedabad, Surat, Vadodara

2023-03-01

Active, closed

Endoscopic Balloon Dilation Versus Endoscopic Stricturotomy for Short Crohn's Strictures

NCT05521867Crohn Disease

Asian Institute of Gastroenterology, India

Not applicable

Hyderabad

2023-02-10

Recruiting

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

NCT05252754Post-ERCP Acute Pancreatitis

DrugsRectal Indomethacin·NSAIDs·Prograf·Tacrolimus

Johns Hopkins University

Phase 3

4,874

Hyderabad, Kolkata, Chandigarh

2023-01-18

Active, closed

ABTECT - Maintenance

NCT05535946Ulcerative Colitis

DrugObefazimod

Abivax S.A.

Phase 3

1,116

Hyderabad, Secunderabad, Ahmedabad, Rajkot, Surat, Vadodara, Gurgaon, Bangalore

2023-01-16

Active, closed

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

NCT05617677Systemic Lupus Erythematosus

DrugDeucravacitinib

Bristol-Myers Squibb

Phase 3

516

Vizianagaram, Ahmedabad, Surat, Gurugram, Bengaluru, Hyderabad

2023-01-12

Active, closed

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

NCT05620407Systemic Lupus Erythematosus

DrugDeucravacitinib

Bristol-Myers Squibb

Phase 3

513

Ahmedabad, Hubli, Mysore, Nagpur, Vellore, Hyderabad, Secundarabad

2023-01-12

Active, closed

A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

NCT05552976Relapsed or Refractory Multiple Myeloma

DrugsMezigdomide·Carfilzomib·Dexamethasone

Bristol-Myers Squibb

Phase 3

606

Gurgaon, Bengaluru, Mumbai, Thane, New Delhi, Mohali, Chennai, Hyderabad

2023-01-10

Active, closed

A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic Anemia

NCT05648968Warm Autoimmune Hemolytic Anemia (wAIHA)

DrugIanalumab

Novartis Pharmaceuticals

Phase 3

New Delhi, Madurai, Hyderabad, Lucknow

2022-12-30

Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

NCT05712200Atrial Fibrillation (AF)

DrugAbelacimab

Anthos Therapeutics, Inc.

Phase 3

2,500

Hyderabad, Kochi, Rudrapur, Ahmedabad, Ajmer, Bangalore, Bhubaneswar, Chandigarh

2022-12-27

Active, closed

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus

NCT05648500Lupus Erythematosus, Systemic

DrugCenerimod

Viatris Innovation GmbH

Phase 3

470

Ahmedabad, Bangalore, Chennai, Hyderabad, Jaipur, Nagpur, Nashik, Pune

2022-12-13

Recruiting

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

NCT05624450Viral Lung Infection and Acute Respiratory Failure

DrugTozorakimab

AstraZeneca

Phase 3

3,527

Ahmedabad, Belagavi, Chennai, Dehradun, Gurugram, Gūrgaon, Hyderabad, Kanpur

2022-12-13

Active, closed

An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis

NCT05626387Hypersensitivity Pneumonitis

DrugsMycophenolate Mofetil·Prednisolone

Post Graduate Institute of Medical Education and Research, Chandigarh

Phase 4

144

Chandigarh, Hyderabad, Jaipur, Jodhpur, Lucknow, New Delhi, Rishikesh, Vellore

2022-11-23

Active, closed

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

NCT05556512Obesity, Overweight

DrugTirzepatide

Eli Lilly and Company

Phase 3

15,374

Ahmedabad, Bikaner, Hyderabad, Lucknow, Ludhiana, Mumbai, Nagpur, New Delhi

2022-10-11

Active, closed

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer

NCT05514054Breast Neoplasms

DrugsImlunestrant·Tamoxifen·Exemestane·Anastrozole

Eli Lilly and Company

Phase 3

8,000

Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Chandigarh, Chennai, Hyderabad, Kanpur

2022-10-04

Recruiting

Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy

NCT05283226Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

DrugPaclitaxel

NATCO Pharma Ltd.

Phase 2

Mumbai, Pune, Hyderabad

2022-09-30

Active, closed

A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

NCT05528510Colitis, Ulcerative

DrugsGuselkumab 1·Guselkumab 2·Guselkumab 3

Janssen Research & Development, LLC

Phase 3

418

Gurugram, Hyderabad, Manipal, Mumbai, Surat

2022-09-13

Recruiting

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

NCT05511363Psychosis Associated With Alzheimer's Disease

DrugKarXT

Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Phase 3

410

Ahmedabad, New Delhi, Hyderabad

2022-08-23

Active, closed

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT05321420Idiopathic Pulmonary Fibrosis

DrugsDeupirfenidone·Pirfenidone

PureTech

Phase 2

240

Vadodara, Bengaluru, Chhatrapati Sambhajinagar, Nagpur, Hyderabad, Kanpur, Kolkata, Belagāve

2022-07-22

Active, closed

A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

NCT05242471Crohn's Disease

DrugsJNJ-78934804·Golimumab·Guselkumab

Janssen Research & Development, LLC

Phase 2

703

Ahmedabad, Bengaluru, Bhubaneswar, Chennai, Gūrgaon, Hyderabad, Mumbai, New Delhi

2022-07-22

Active, closed

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT04975997Multiple Myeloma

DrugsIberdomide·Bortezomib·Daratumumab·Dexamethasone

Celgene

Phase 3

939

Hyderabad, Bangalore, Ernākulam, Mumbai, Kolkata, Puducherry

2022-06-23

By invitation

Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

NCT05248659Immunoglobulin A Nephropathy

DrugSibeprenlimab

Otsuka Pharmaceutical Development & Commercialization, Inc.

Phase 2/3

600

Hyderabad, Ahmedabad, Nadiād, Bengaluru, Manipal, Kozhikode, Thiruvananthapuram, Pune

2022-04-05

Active, closed

Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC

NCT05301842Hepatocellular Carcinoma

DrugsTremelimumab·Durvalumab·Lenvatinib

AstraZeneca

Phase 3

760

Ahmedabad, Bangalore, Delhi, Hyderabad, Jaipur, Kolkata, Mumbai, New Delhi

2022-03-28

Active, closed

A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC

NCT05211895Non-Small Cell Lung Cancer

DrugsDomvanalimab·Durvalumab

AstraZeneca

Phase 3

791

Ahmedabad, Bangalore, Delhi, Howrah, Hyderabad, Jaipur, Kolkata, Marg Jaipur

2022-02-18

Active, closed

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis

NCT05138133Lupus Nephritis

DrugAnifrolumab

AstraZeneca

Phase 3

363

Ahmedabad, Dehradun, Delhi, Hyderabad, Kolkata, Nadiād, Pune, Secunderabad

2022-02-15

Active, closed

Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)

NCT04954859Hepatitis B

DrugBepirovirsen

GlaxoSmithKline

Phase 2

366

Belagavi, Coimbatore, Hyderabad, Kanchan Bagh Hyderabad, Mumbai, New Delhi, Pune, Surat

2021-12-14

Active, closed

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

NCT05156281Relapsing Multiple Sclerosis

DrugsTeriflunomide·Remibrutinib

Novartis Pharmaceuticals

Phase 3

1,007

Kochi, Pune, New Delhi, Amritsar, Hyderabad, Lucknow, Kolkata

2021-12-13

Active, closed

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

NCT05152147Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma

DrugsZanidatamab·Herceptin·Trastuzumab·Adrucil

Jazz Pharmaceuticals

Phase 3

920

Bhubaneswar, Gūrgaon, Hyderabad, New Delhi, Patna, Vijayawada

2021-12-02

Active, closed

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

NCT05030428Atherosclerotic Cardiovascular Disease

DrugInclisiran sodium

Novartis Pharmaceuticals

Phase 3

17,004

Guntur, Hyderabad, Ahmedabad, Vadodara, Belagavi, Manipal, Mysore, Kochi

2021-11-23

Active, closed

A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations

NCT05048797Locally Advanced or Metastatic Non-Small Cell Lung Cancer

DrugsTrastuzumab deruxtecan·Pemetrexed·Cisplatin·Carboplatin

AstraZeneca

Phase 3

454

Bangalore, Delhi, Hyderabad, Mumbai, Nashik

2021-10-28

Active, closed

A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)

NCT05104866Breast Cancer

DrugsEribulin·Dato-DXd·Vinorelbine·Capecitabine

AstraZeneca

Phase 3

732

Gūrgaon, Howrah, Hyderabad, Jaipur, Kolkata, Nashik, Surat, Visakhapatnam

2021-10-18

Active, closed

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

NCT04975308Breast Neoplasms, Neoplasm Metastasis

DrugsImlunestrant·Exemestane·Abemaciclib·Fulvestrant

Eli Lilly and Company

Phase 3

874

Bangalore, Thiruvananthapuram, Mumbai, Nagpur, Nashik, Pune, Hyderabad

2021-10-04

Recruiting

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

NCT04557462Primary IgA Nephropathy

DrugIptacopan

Novartis Pharmaceuticals

Phase 3

540

Bangalore, New Delhi, Hyderabad

2021-09-20

Recruiting

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

NCT04817618C3G

DrugIptacopan

Novartis Pharmaceuticals

Phase 3

New Delhi, Hyderabad, Lucknow, Dehradun

2021-07-28

Active, closed

Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

NCT04229979Acute Myeloid Leukemia

DrugsGm-Csf·Sargramostim·Ara-C·Decitabine

Sellas Life Sciences Group

Phase 3

127

Kannur, Hyderabad, Ludhiāna, New Delhi, Patna

2021-02-08

Active, closed

A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

NCT04624659Sickle Cell Disease

DrugEtavopivat

Forma Therapeutics, Inc.

Phase 3

450

Mumbai, Hyderabad, Bangalore, Cutack, New Delhi

2021-01-29

Recruiting

Secukinumab Open Label Roll-over Extension Protocol

NCT04638647Autoimmunity, Inflammation

DrugSecukinumab

Novartis Pharmaceuticals

Phase 4

1,000

Surat, Bangalore, Mumbai, Nashik, New Delhi, Hyderabad

2020-12-22

Active, closed

Atrasentan in Patients With IgA Nephropathy

NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy

DrugsAtrasentan·Zigakibart

Novartis Pharmaceuticals

Phase 3

404

Kozhikode, Pune, Vellore, Hyderabad, Secunderabad, Kolkata

2020-12-11

Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

NCT04613596Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

DrugsAdagrasib·Pembrolizumab

Mirati Therapeutics Inc.

Phase 2/3

626

Ahemdabad, Ahmedabad, Bangalore, Belagavi, Chhatrapati Sambhajinagar, Howrah, Hyderabad, Jaipur

2020-12-02

Active, closed

Myasthenia Gravis Inebilizumab Trial

NCT04524273Myasthenia Gravis

DrugInebilizumab

Amgen

Phase 3

238

Nagpur, Hyderabad, Bangalore, Lucknow, Manipal, Nashik, Pune, Surat

2020-10-15

Active, closed

A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions

NCT04538664Carcinoma, Non-Small-Cell Lung

DrugsAmivantamab·Pemetrexed·Carboplatin

Janssen Research & Development, LLC

Phase 3

308

Hyderabad, Kolkata, Mumbai, Nashik, New Delhi, Pune

2020-10-13

Active, closed

A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT04487080Carcinoma, Non-Small-Cell Lung

DrugsLazertinib·Amivantamab·Osimertinib

Janssen Research & Development, LLC

Phase 3

1,074

Hyderabad, Kolkata, Mumbai, Nashik, Pune

2020-09-30

Recruiting

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

NCT04462770Dravet Syndrome

DrugClemizole HCl

Epygenix

Phase 3

150

Hyderabad, Surat, Belagavi, Bengaluru, Kochi, Pune, Mumbai, Nagpur

2020-09-15

Active, closed

MINIject Global Long-Term Follow-up Study

NCT04524416Open Angle Glaucoma, Ocular Hypertension

iSTAR Medical

Observational

116

Hyderabad

2020-08-05

Active, closed

A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)

NCT03992430Muscular Dystrophy, Duchenne

DrugEteplirsen

Sarepta Therapeutics, Inc.

Phase 3

160

Ahmedabad, Bengaluru, Hyderabad, Madurai, New Delhi, Pune, Vellore

2020-07-13

Active, closed

Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)

NCT04314531Active Psoriatic Arthritis

Sun Pharmaceutical Industries Limited

Phase 3

296

Surat, Bangalore, Belagavi, Hubli, Pune, Hyderabad, Lucknow, Kochi

2020-07-01

Active, closed

Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

NCT04273945Pulmonary Arterial Hypertension

DrugMacitentan

Actelion

Phase 3

935

Ahmedabad, Bangalore, Chengalpetu, Coimbatore, Durgapur, Hyderabad, Hyderbad, Kolkata

2020-06-30

Recruiting

Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

NCT04143724Beta-Thalassemia

DrugLuspatercept

Celgene

Phase 2

Hyderabad, Mumbai, Nagpur, Noida, Kolkata, Vellore

2019-11-07

Active, closed

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT03983954ER+ Breast Cancer, Ovarian Cancer, Cervical Squamous Cell Carcinoma, Pancreatic Adenocarcinoma

NeoTX Therapeutics Ltd.

Phase 1

120

Ahmedabad, Jhajjar, New Delhi, Udaipur, Hyderabad

2019-10-10

Active, closed

SyncAV Post-Market Trial

NCT04100148Congestive Heart Failure

Abbott Medical Devices

Not applicable

1,686

Hyderabad, Ahmedabad, Bangalore, Gūrgaon, New Delhi

2019-10-03

Active, closed

Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients

NCT03814746Sickle Cell Disease (SCD)

DrugCrizanlizumab

Novartis Pharmaceuticals

Phase 3

253

Bhubaneswar, Hyderabad

2019-07-26

Active, closed

ASP-1929 Photoimmunotherapy (PIT) Study in Recurrent Head/Neck Cancer for Patients Who Have Failed at Least Two Lines of Therapy

NCT03769506Head and Neck Cancer

Rakuten Medical, Inc.

Phase 3

135

Vadodara, Bangalore, Kochi, Chennai, Hyderabad, Kolkata, Mumbai

2019-05-09

Active, closed

PROSpect: Prone and Oscillation Pediatric Clinical Trial

NCT03896763Acute Respiratory Distress Syndrome in Children

University of Pennsylvania

Not applicable

600

Hyderabad

2019-05-01

Active, closed

Intra-operative Pancreatoscopy in Patients With IPMN

NCT03729453Intraductal Papillary Mucinous Neoplasm

Boston Scientific Corporation

Observational

100

Hyderabad

2019-03-20

Active, closed

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

NCT03650114Relapsing Multiple Sclerosis

Drugs13-valent pneumococcal conjugate vaccine·23-valent pneumococcal polysaccharide vaccine·Ofatumumab

Novartis Pharmaceuticals

Phase 3

1,882

Mangalore, Kochi, Mumbai, Pune, New Delhi, Chandigarh, Hyderabad, Howrah

2018-12-28

Active, closed

A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma

NCT03778957Hepatocellular Carcinoma

DrugsAvastin·Durvalumab·Bevacizumab

AstraZeneca

Phase 3

724

Bangalore, Bengaluru, Hyderabad, Kolkata, Madurai, Mumbai, Nashik, Pune

2018-11-30

Active, closed

A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

NCT03519945Ulcerative Colitis

DrugMirikizumab

Eli Lilly and Company

Phase 3

1,058

Ahmedabad, Bangalore, Hyderabad, Jaipur, Ludhiana, Nagpur, Noida, Pune

2018-07-18

Active, closed

International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer

NCT03386734Cervical Cancer

Centre Hospitalier Universitaire de Besancon

Not applicable

989

Hyderabad, Kolkata

2018-05-03

Active, closed

Efficacy Of Bovine Colostrum In The Treatment Of Severe Alcohol-Associated Hepatitis: A Randomized Controlled Trial

NCT02473341Alcoholic Hepatitis

Dayanand Medical College and Hospital

Phase 3

174

Ludhiana, Chandigarh, Hyderabad, Jaipur, New Delhi

2017-11-14

Recruiting

UNITY-B A Prospective, Multicentric, Single-arm Study to Evaluate the Safety and Efficacy of the UNITY-B Biodegradable Balloon-Expandable Biliary Stent System in Subjects With Biliary Strictures

NCT04929821Biliary Obstruction, Bile Duct Stricture, Bile Duct Diseases

QualiMed Innovative Medizinprodukte GmbH

Not applicable

100

Hyderabad

2017-10-16

Active, closed

Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

NCT03298451Hepatocellular Carcinoma

DrugsSorafenib·Tremelimumab·Durvalumab

AstraZeneca

Phase 3

1,324

Bangalore, Bhubneshwar, Chennai, Hubli, Hyderabad, Karmsad, Mumbai, Nashik

2017-10-11

Active, closed

Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer

NCT03155997Breast Cancer

DrugAbemaciclib

Eli Lilly and Company

Phase 3

5,637

Hyderabad, Ahmedabad, Vadodara, Gurgaon, Bangalore, Trivandrum, Mumbai, Nashik

2017-07-12

Active, closed

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis

DrugPacritinib

Swedish Orphan Biovitrum

Phase 3

407

Guwahati, Chandigarh, Surat, Gurgaon, Pune, Jaipur, Madurai, Hyderabad

2017-06-26

By invitation

A Clinical Registry of Orthobiologics Procedures

NCT03011398Orthopedic Disorder

Regenexx, LLC

Observational

50,000

Hyderabad

2016-02

Active, closed

A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients

NCT03127631Prostate Cancer, Cardiovascular Disease

McMaster University

Not applicable

5,000

Sītāpura, Bengaluru, Bangalore, Hyderabad

2015-10-21

Recruiting

Product Surveillance Registry

NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders

Medtronic

Observational

100,000

Jaipur, Hyderabad, Bangalore, Bengaluru, Chennai, Gūrgaon, Kochi, New Delhi

2012-01

Active, closed

Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.

NCT00099437Breast Cancer

DrugFulvestrant

AstraZeneca

Phase 3

736

Ansārinagar, Bhopal, Hyderabad, Jaipur, Kolkata, Manipal, Marg Jaipur, Mumbai

2005-02-13

Recruiting

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

NCT00271180Arrhythmia, Bradycardia, Heart Failure, Sinus Tachycardia

Medtronic

Observational

20,000

Bangalore, Chennai, Gūrgaon, Hyderabad, Jaipur, Kochi, New Delhi, Vadapalani

1983-01

Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 7 November 2026. https://priyalifescience.com/clinical-trials-india/city/hyderabad

Query this register directly

GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in India and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,120 studies in total at the last sync on 07 Nov 2026, 03:16 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 233 of those studies with a site in Hyderabad.

How many clinical trials are recruiting in Hyderabad?

136 of the 233 studies on this page are recruiting new participants as of the 07 Nov 2026, 03:16 UTC sync. A further 9 have not yet opened recruitment, 83 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Hyderabad), 233 studies
Phase	Studies	Recruiting	Share
Phase 3	122	66	52.4%
Not applicable	38	21	16.3%
Observational	26	19	11.2%
Phase 2	22	13	9.4%
Phase 4	11	7	4.7%
Phase 2/3	8	5	3.4%
Phase 1	5	4	2.1%
Phase 1/2	1	1	0.4%

Most active sponsors

Lead sponsors with the most studies (Hyderabad)
Lead sponsor	Studies	Recruiting
Asian Institute of Gastroenterology, India	39	29
AstraZeneca	37	21
Bristol-Myers Squibb	15	9
Eli Lilly and Company	14	8
Novartis Pharmaceuticals	14	5
Janssen Research & Development, LLC	10	4
Novo Nordisk A/S	5	4
GlaxoSmithKline	4	3
Boehringer Ingelheim	3	3
Celgene	3	2

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.